Comparison of various steady state surrogate insulin resistance indices in diagnosing metabolic syndrome

[1] Morales Villegas E(2006)Syndrome X vs metabolic syndrome Arch Cardiol Mex 76 S173-S188

[2] Parikh RM(2012)Changing definitions of metabolic syndrome Indian J Endocrinol Metab 16 7-12

[3] Mohan V(2010)The metabolic syndrome—new and old data Rom J Intern Med 48 193-203

[4] Pîrcălăboiu L(2017)The criteria for metabolic syndrome and the national health screening and education system in Japan Epidemiol Health 39 e2017003-42

[5] Popa S(2018)Metabolic syndrome and associated diseases: from the bench to the clinic Toxicol Sci 162 36-E26

[6] Puiu I(2008)Current approaches for assessing insulin sensitivity and resistance in vivo: advantages, limitations, and appropriate usage Am J Physiol Endocrinol Metab 294 E15-47

[7] Dinu RI(2010)Surrogate markers of insulin resistance: a review World J Diabetes 1 36-190

[8] Dinu F(2015)Biomarkers of insulin sensitivity and insulin resistance: past, present and future Crit Rev Clin Lab Sci 52 180-441

[9] Moţa M(2017)Adiponectin-resistance in obesity Adv Exp Med Biol 960 415-229

[10] Yamagishi K(2002)Disordered fat storage and mobilization in the pathogenesis of insulin resistance and type 2 diabetes Endocr Rev 23 201-1217

[1] Morales Villegas E(2006)Syndrome X vs metabolic syndrome Arch Cardiol Mex 76 S173-S188

[2] Parikh RM(2012)Changing definitions of metabolic syndrome Indian J Endocrinol Metab 16 7-12

[3] Mohan V(2010)The metabolic syndrome—new and old data Rom J Intern Med 48 193-203

[4] Pîrcălăboiu L(2017)The criteria for metabolic syndrome and the national health screening and education system in Japan Epidemiol Health 39 e2017003-42

[5] Popa S(2018)Metabolic syndrome and associated diseases: from the bench to the clinic Toxicol Sci 162 36-E26

[6] Puiu I(2008)Current approaches for assessing insulin sensitivity and resistance in vivo: advantages, limitations, and appropriate usage Am J Physiol Endocrinol Metab 294 E15-47

[7] Dinu RI(2010)Surrogate markers of insulin resistance: a review World J Diabetes 1 36-190

[8] Dinu F(2015)Biomarkers of insulin sensitivity and insulin resistance: past, present and future Crit Rev Clin Lab Sci 52 180-441

[9] Moţa M(2017)Adiponectin-resistance in obesity Adv Exp Med Biol 960 415-229

[10] Yamagishi K(2002)Disordered fat storage and mobilization in the pathogenesis of insulin resistance and type 2 diabetes Endocr Rev 23 201-1217